|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00959556 |
|
Date of registration:
|
13/08/2009 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Study of Blood Samples in Patients With Breast Cancer
|
|
Scientific title:
|
Search for Genetic Factors Predictive of Response to Chemotherapy in Patients With or Who Has a Mammary Adenocarcinoma in Neo-adjuvant or Metastatic Setting |
|
Date of first enrolment:
|
November 2007 |
|
Target sample size:
|
900 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00959556 |
|
Study type:
|
Observational |
|
Study design:
|
N/A
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Jacques Bonneterre, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Centre Oscar Lambret |
|
|
Name:
|
Jacques Bonneterre, MD, PhD |
|
Address:
|
|
|
Telephone:
|
33-3-20-29-5959 |
|
Email:
|
j.bonneterre@o-lambret.fr |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
DISEASE CHARACTERISTICS:
- Histologically confirmed breast carcinoma
- Received first-line chemotherapy (in neoadjuvant or metastatic setting) comprising
anthracyclines and/or taxanes, including for a second primary cancer
- Patient agrees to conservative surgery
- Hormone receptor status not specified
PATIENT CHARACTERISTICS:
- Menopausal status not specified
- No contraindication for chemotherapy comprising anthracyclines and/or taxanes
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No prior adjuvant therapy
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Breast Cancer
|
|
Intervention(s)
|
|
Other: laboratory biomarker analysis
|
|
Primary Outcome(s)
|
|
Histologic complete response (Chevallier and Sataloff) or tumor response (RECIST)
[Time Frame: No]
|
|
Secondary ID(s)
|
|
CDR0000633531
|
|
COL-IDRCB-2007-A00908-45
|
|
COL-GENEOM
|
|
COL-2007-08
|
|
INCA-RECF0635
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|